Login
$CRVW
$0.04 +$0.00 (0.0%) Close

$CRVW 4/A SEC Filings

Filed On Filing
31 Jan 2023 Form 4/A: McRee Sandra K, COO

Disposed of 0 Secured Convertible Note (Disposition to Issuer) · Granted 0 Secured Convertible Note

31 Jan 2023 Form 4/A: Wheeler L. Allen, Director

Disposed of 0 Secured Convertible Note (Disposition to Issuer) · Granted 0 Secured Convertible Note

31 Jan 2023 Form 4/A: Epstein Steven B, Director

Disposed of 0 Secured Convertible Note (Disposition to Issuer) · Granted 0 Secured Convertible Note

31 Jan 2023 Form 4/A: Lightcap Jeffrey C, Director

Disposed of 0 Secured Convertible Note (Disposition to Issuer) · Granted 0 Secured Convertible Note

31 Jan 2023 Form 4/A: Higgins James R, Director

Disposed of 0 Secured Convertible Note (Disposition to Issuer) · Granted 0 Secured Convertible Note

31 Jan 2023 Form 4/A: Johnson Steven G., Director

Disposed of 0 Secured Convertible Note (Disposition to Issuer) · Granted 0 Secured Convertible Note

26 Apr 2017 Form 4/A: Wheeler L. Allen, Director

Bought 42,398 shares ($7.42K) · Bought 347,179 shares ($69.4K)

26 Apr 2017 Form 4/A: Wheeler L. Allen, Director

Bought 180,750 shares ($24.9K) · Bought 439,273 shares ($65.9K) · Bought 200,000 shares ($31K)

26 Apr 2017 Form 4/A: Wheeler L. Allen, Director

Bought 130,400 shares ($20.9K)

26 Apr 2017 Form 4/A: White David Richard, Director

Bought 100,000 shares ($16.9K) · Bought 170,000 shares ($32.8K)

20 Apr 2017 Form 4/A: Wheeler L. Allen, Director

Received 130,400 shares as a grant or award ($20.9K)

20 Apr 2017 Form 4/A: Wheeler L. Allen, Director

Received 180,750 shares as a grant or award ($24.9K) · Received 439,273 shares as a grant or award ($65.9K) · Received 200,000 shares as a grant or award ($31K)

20 Apr 2017 Form 4/A: Epstein Steven B, Director

Bought 50,000 shares ($8K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support